Tradelink 2018 Annual Report

Directors’ Report (Continued) 董事會報告書 （續） 81 二零一八年年報 貿易通電子貿易有限公司 董事於股份、相關股份及債權 證的權益及淡倉 於二零一八年十二月三十一日，非執行董事李乃 熺 博士， S.B.S., J.P. 分別透過其於聯業製衣有限公 司擁有的間接股權，在本公司當作持有的權益為 101,125,000 股，以及透過其於 Eastex (HK) Limited 擁 有 的 直 接 股 權，在 本 公 司 股 份 中 擁 有 95,673,000 股。非執行董事李國本博士透過其於 聯業製衣有限公司擁有的間接股權，在本公司當 作持有的權益為 101,125,000 股。李乃 熺 博士， S.B.S., J.P. 及李國本博士在本公司當作持有的權益 為 101,125,000 股 與 聯 業 製 衣 有 限 公 司 持 有 的 101,125,000 股是相同的一批股份。按本公司根據 《證券及期貨條例》（「證券及期貨條例」）第 352 條規 定須予備存的登記冊所載記錄顯示，謝錦強先 生、鄭俊聰先生及鍾順群女士（均為本公司執行 董事）現時分別以個人名義持有 4,070,000 股、 2,755,843 股及 2,994,605 股本公司普通股。 本公司董事可享有本公司購股權計劃的購股權， 有關詳情載於下文「購股權計劃」一節。 除上文所述外，按本公司根據證券及期貨條例第 352 條規定須予備存的登記冊所載記錄顯示，本 公司董事或任何彼等的配偶或十八歲以下的子女 概無在本公司、其任何控股公司、附屬公司或其 他相聯法團的股份、相關股份或債權證中擁有權 益或淡倉，或根據上市公司董事進行證券交易的 標準守則已另行知會本公司的權益或淡倉。 購股權計劃 本公司現時的購股權計劃於二零一四年五月九日 獲採納（「二零一四年購股權計劃」）。根據二零 一四年購股權計劃，董事會可全權酌情向本公司 或本集團旗下任何公司的任何僱員（不論全職或 兼職）、董事（包括獨立非執行董事）、專業顧問、 業務夥伴或諮詢顧問授出可認購本公司股份的購 股權，惟任何十二個月期間內已發行或將發行予 任何一名承授人的股份總數不得超過本公司已發 行股份的 1% 。接納購股權要約時，承授人須向 本公司支付港幣 1.00 元，作為獲授購股權的象徵 式代價。每份購股權的行使期均為十年且歸屬條 件詳情載列於第 185 頁至第 187 頁「財務報表附註」 內的 附註 24(a) 。二零一四年購股權計劃將於二零 二四年五月八日屆滿。然而，於屆滿前根據該購 股權計劃授出的購股權將仍然有效，並受相同條 款及條件所限。 Directors’ Interests and Short Positions in S h a r e s , Un d e r l y i n g S h a r e s a n d Debentures As at 31 December 2018, Dr. LEE Nai Shee, Harry, S.B.S., J.P. , a Non- executive Director, had a deemed interest in 101,125,000 shares of the Company through his indirect shareholding in TAL Apparel Limited and 95,673,000 shares in the Company through his direct shareholding in Eastex (HK) Limited respectively. Dr. LEE Delman, a Non-executive Director, had a deemed interest in 101,125,000 shares of the Company through his indirect shareholding in TAL Apparel Limited. The deemed interests 101,125,000 shares of the Company held by Dr. LEE Nai Shee, Harry, S.B.S., J.P. and Dr. LEE Delman were the same shares held by TAL Apparel Limited. Mr. TSE Kam Keung, Mr. CHENG Chun Chung, Andrew and Ms. CHUNG Shun Kwan, Emily, Executive Directors of the Company, held 4,070,000, 2,755,843 and 2,994,605 ordinary shares of the Company registered in their own names respectively as recorded in the register required to be kept under Section 352 of the Securities and Futures Ordinance (“SFO”). The Directors of the Company are entitled to options under the share option schemes of the Company, details of which are set out in the section “Share Option Scheme” below. Apart from the foregoing, none of the Directors of the Company or any of their spouses or children under eighteen years of age has interest or short positions in shares, underlying shares or debentures of the Company, any of its holding company, subsidiaries or other associated corporations, as recorded in the register required to be kept under Section 352 of the SFO or as otherwise notified to the Company pursuant to the Model Code for Securities Transactions by Directors of Listed Companies. Share Option Scheme The Share Option Scheme currently in operation was adopted on 9 May 2014 (the “Share Option Scheme 2014”). Under the Share Option Scheme 2014, the Board has the absolute discretion to offer any employees (whether full or part-time), directors (including Independent Non-executive Directors), consultants, business associates or advisers of the Company or any company within the Group options to subscribe for shares of the Company, provided that the total number of shares issued or to be issued to any one grantee in any 12-month period shall not exceed 1% of the shares of the Company in issue. The grantee shall pay HK$1.00 to the Company as nominal consideration for the grant upon acceptance of the offer of an option. Each option has a 10-year exercise period and the details of vesting conditions are set out in Note 24(a) under the heading “Notes to the Financial Statements” on pages 185 to 187. The Share Option Scheme 2014 will expire on 8 May 2024. However, share options granted under this Share Option Scheme before its expiry date will remain valid, subject to the same terms and conditions.